Compounds > 5,7-dihydroxytryptamine
Page last updated: 2024-08-23

5,7-dihydroxytryptamine and cgs 12066b

5,7-dihydroxytryptamine has been researched along with cgs 12066b in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Reid, A; Sawynok, J1
Goldstein, DS; Kopin, IJ; Pacak, K; Yadid, G1

Other Studies

2 other study(ies) available for 5,7-dihydroxytryptamine and cgs 12066b

ArticleYear
Spinal supersensitivity to 5-HT1, 5-HT2 and 5-HT3 receptor agonists following 5,7-dihydroxytryptamine.
    European journal of pharmacology, 1994, Nov-03, Volume: 264, Issue:3

    Topics: 5,7-Dihydroxytryptamine; Amphetamines; Analgesia; Analgesics; Analysis of Variance; Animals; Binding Sites; Indoles; Injections, Spinal; Male; Pain; Piperazines; Quinoxalines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Up-Regulation

1994
Endogenous serotonin stimulates striatal dopamine release in conscious rats.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 270, Issue:3

    Topics: 5,7-Dihydroxytryptamine; Alanine; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Male; Microdialysis; Perfusion; Piperazines; Quinoxalines; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Receptor Agonists

1994